It can help identify people at risk of Alzheimer's disease and screen for conditions like Parkinson's disease, brain tumors, substance abuse, and head trauma. Introduced in 2005, the MoCA test is an ...
If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...
NEW YORK — When Dr. Alois Alzheimer first identified the disease that would bear his name in 1906, he could only confirm his diagnosis by examining brain tissue after a patient’s death. More than a ...
Dr. Nasca says that if further studies confirm their latest findings, the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease ...
If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...
A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA, which could help it ...
The team’s goal is to define other biomarkers in the brain that track closely with Alzheimer’s disease progression. If further studies confirm their latest findings, Nasca says the team’s research ...